Free tool

Oncology stocks

We cover 10 companies grouped under the Oncology theme. The median market value in the group is $408.78M. Across the group, the median move over the past trading day is +0.25%. Price change over the past year runs from −12.0% to +251.1% across the middle 80 percent of the group, with a median of +18.7%.

Other lists in this group

Table

10 of 319 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
0J9P.LIncyte Corporation$21.10BLarge cap+53.49%
GE9.DEGenmab A/S$20.65BLarge cap−11.12%
0M2N.LOrion Oyj$11.16BLarge cap+20.48%
0SZI.LCorbus Pharmaceuticals Holdings, Inc.$707.84MSmall cap+9.60%
0LOV.LVerastem, Inc.$470.33MSmall cap−19.93%
0XOD.LUroGen Pharma Ltd.$347.24MSmall cap+136.88%
0QXX.LMolecular Partners AG$79.34MMicro cap+17.00%
SAR.LSareum Holdings plc$70.10MMicro cap+76.19%
CRTX.LCRISM Therapeutics Corporation$12.38MMicro cap+9.52%
0NWK.LValerio Therapeutics Société anonyme$10.08MMicro cap+1279.03%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse